LSE - Delayed Quote GBp
Shield Therapeutics plc (STX.L)
2.3500
+0.0900
+(3.98%)
At close: April 25 at 4:08:39 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-37,126
-37,126
-22,591
-24,647.0699
-1,907.9548
Investing Cash Flow
-2,430
-2,430
-2,249
-2,768.1054
-27.2565
Financing Cash Flow
49,656
49,656
8,530
37,401.1391
-64.0528
End Cash Position
13,948
13,948
3,402
16,353.5509
4,006.7051
Capital Expenditure
-2,948
-2,948
-2,285
-2,785.6507
-31.3450
Issuance of Capital Stock
26,817
26,817
105
37,391.6916
8.1769
Issuance of Debt
29,446
29,446
9,080
--
--
Repayment of Debt
-5,448
-5,448
--
--
--
Repurchase of Capital Stock
--
--
-100
--
--
Free Cash Flow
-40,074
-40,074
-24,876
-27,432.7206
-1,939.2998
12/31/2020 - 2/26/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AEQ.F Aequus Pharmaceuticals Inc.
0.0005
0.00%
5SS0.F Simply Better Brands Corp.
0.5340
+3.49%
GENIL.IS Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi
121.30
+1.08%
GABA.ST Gabather AB (publ)
0.0396
-2.94%
VCBD Vitalibis, Inc.
0.0018
+28.57%
GHG.CN Global Hemp Group Inc.
0.0200
0.00%
KLAR.ST Klaria Pharma Holding AB (publ.)
1.1500
-3.77%
TGIF.CN 1933 Industries Inc.
0.0050
0.00%
4502.T Takeda Pharmaceutical Company Limited
4,275.00
+0.38%
CRNO-B.ST Cereno Scientific AB (publ)
8.00
+0.38%